- 🇸🇦 Saudi Stock Market
- 🇺🇸 USA Stock Market
Teva Pharmaceutical Industries Ltd., commonly known as Teva Pharma, is one of the largest pharmaceutical companies globally, specializing in generic and specialty medicines. Founded in 1901 in Jerusalem, Israel, Teva has grown into a multinational corporation with operations in over 60 countries. Teva’s primary focus is on developing, manufacturing, and marketing a wide range of generic and specialty medicines, including both branded and non-branded pharmaceuticals. The company produces medications across various therapeutic areas, such as central nervous system (CNS) disorders, respiratory diseases, oncology, pain management, and more.
TEVA — NYSE —
Current RSI of this stock is 83.18, which indicates the strength of buyers.
Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
The short length exponential moving average (10 EMA) has crossed the long length moving average (20 EMA) from the below, generates bullish signal. Last day’s candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.
Based on our short term trading in USA stocks, Teva Pharmaceutical Industries stock price target will be USD 17.6 - USD 18 in the next 10-12 trading sessions.
Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.
Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.
Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.
If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website
